Tamoxifen citrate
FDA Approved
Contents
Description
Tamoxifen is a selective estrogen receptor modulator (SERM) primarily used in breast cancer treatment. It has demonstrated efficacy in treating aggressive fibromatosis (desmoid tumors) and superficial fibromatosis by inhibiting fibroblast proliferation. Off-label use includes various fibroproliferative disorders.
Indications & Therapeutic Use
aggressive fibromatosis, desmoid tumors, superficial fibromatosis, Dupuytren contracture
Linked Diseases:
Global Availability (10 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Tamoxifen citrate — GNH India
62 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Adifen 10mg
EU
Kessar
EU
Nolvadex
EU
Nolvadex D
EU
Nolvadex-D
EU
Nomafen
EU
Sertam
EU
Tamoplex
EU
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Tamoxifen citrate
| Generic Name | tamoxifen citrate |
| Brands | 1 brand available |
| Active Ingredient | tamoxifen citrate |
| Drug Class | aggressive fibromatosis |
| Manufacturer | AstraZeneca |
| Dosage Forms | Oral tablets 10mg, 20mg |
| Medical Code | L02BA01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 5 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT00001704 |
| Countries | 10 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations11 Validated Nodes